MedPath

Endoscopic Treatment of Bronchial Carcinoid Tumors

Completed
Conditions
Carcinoid Tumor
Registration Number
NCT03723499
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

Carcinoid tumors of the lung are considered to be a low-grade malignancy. Surgical resection is considered the standard approach. Recent data has shown that a complete endoscopic treatment could be considered. An endoscopic treatment is can be a alternative to invasive surgery.

Detailed Description

The objective of this study is to evaluate the feasibility and therapeutic method of endoscopic treatment of bronchial carcinoid tumors.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Patients treated by endoscopic approach for a carcinoid tumor at the University Hospital Centre of Saint-Etienne between November 1995 to December 2017.
Exclusion Criteria
  • Patients treated for a recurrence of carcinoid tumor.
  • Patients with metastatic disease.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complete endoscopic treatmentMonth 1

patients who have a complete endoscopic treatment

Secondary Outcome Measures
NameTimeMethod
Type of endoscopic method usedMonth 1

Analysis type of endoscopic method used.

Tumor localizationMonth 1

Analysis the tumor localization.

Deadline before recurrence10 years

Analysis the deadline before recurrence of the tumor.

Trial Locations

Locations (1)

CHU de Saint-Etienne

🇫🇷

Saint-Étienne, France

CHU de Saint-Etienne
🇫🇷Saint-Étienne, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.